Jeong Soo Ok

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
Cell therapies using mesenchymal stem cells (MSCs) and endothelial progenitor cells (EPCs) are increasing in regenerative medicine, with applications to a growing number of aging-associated dysfunctions and degenerations. For successful therapies, a certain mass of cells is needed, requiring extensive ex vivo expansion of the cells. However, the(More)
  • 1